Catégorie : Publications récentes

Harmful Effects of Smoking Cannabis : A Cerebrovascular and Neurological Perspective, Sabrina Rahman Archie et al., 2019

Harmful Effects of Smoking Cannabis : A Cerebrovascular and Neurological Perspective Sabrina Rahman Archie and Luca Cucullo Frontiers in Pharmacology, 2019, 10, Article 1481. doi : 10.3389/fphar.2019.01481   Apart from being used as a medicine, cannabis or marijuana is the most widely abused recreational drug all over the world. The legalization and decriminalization of cannabis in Canada and various states of USA may be the underlying reason of the widespread popularity of it among young population. Various studies have reported about the relationship between cannabis use and different detrimental effects like cardiovascular, cerebrovascular, and neurological complications among different age groups. Specifically, the young population is [...]

Lire la suite

Cannabis use in pediatric cancer patients : what are they reading ? A review of the online literature, M. Yeung et al., 2020

Cannabis use in pediatric cancer patients : what are they reading ? A review of the online literature. YEUNG M., WROOT H., CHARNOCK C., FORBES C., LAFAY-COUSIN L., SCHULTE F. Support Care Cancer, 2020. doi: 10.1007/s00520-020-05306-2 Abstract BACKGROUND: Recent changes to the legal status of marijuana in Canada warrant a review of the information that patients and families are accessing online regarding the role of cannabis in cancer. The aims of the current research were to identify the quality of literature available online as well as the themes, and opinion (i.e., pro-, neutral, or anti-cannabis) of online articles. METHODS: Searches were conducted using three primary search engines: Google, [...]

Lire la suite

Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV, Caitlin Wei-Ming Watson et al., 2020

Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV Caitlin Wei-Ming Watson, Emily W. Paolillo, Erin E. Morgan, Anya Umlauf, Erin E. Sundermann, Ronald J. Ellis, MD, Scott Letendre, Thomas D. Marcotte, Robert K. Heaton, and Igor Grant Journal of Acquired Immune Deficiency Syndromes, 2020, 83, (1), 56–64. Doi : 10.1097/QAI.0000000000002211   Background : Aging and HIV have adverse effects on the central nervous system, including increased inflammation and neural injury and confer risk of neurocognitive impairment (NCI). Previous research suggests the nonacute neurocognitive effects of cannabis in the general population are adverse or null. However, in the [...]

Lire la suite

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations, Alfredo Pascual, Marijuana Business Daily, 15 janvier 2020

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations Published January 15, 2020 | By Alfredo Pascual https://mjbizdaily.com/european-commission-proposes-unified-eu-vote-on-who-cannabis-scheduling-recommendations/?utm_medium=email&utm_source=newsletter&utm_campaign=INTL_20200115_NEWS_Weekly   In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations. The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by the Council of Europe – the EU countries would vote as a block at the CND session in Vienna and the three motions [...]

Lire la suite

Le cannabigerol est efficace contre les infections par des bactéries résistantes aux antibiotiques, The Guardian du 19 Janvier 2020

Le cannabigerol est efficace contre les infections par des bactéries résistantes aux antibiotiques Le cannabigérol (CBG), un cannabinoïde de la plante de cannabis, s’avère pouvoir détruire les bactéries résistantes aux médicaments, suscitant l’espoir d’une nouvelle arme dans la lutte contre les superbactéries. Les scientifiques ont examiné cinq cannabinoïdes pour leurs propriétés antibiotiques et ont découvert que le cannabigérol (CBG) était particulièrement puissant pour tuer le Staphylococcus aureus résistant à la méthicilline (SARM), l’une des super-bactéries les plus courantes dans les hôpitaux. Après avoir vu l’efficacité de la substance contre les bactéries en laboratoire, les chercheurs ont décidé de tester la capacité du [...]

Lire la suite

Neurocognitive Consequences of Chronic CannabisUse : A Systematic Review and Meta-Analysis, Pedro Rafael Figueiredo et al., 2019

Neurocognitive Consequences of Chronic CannabisUse : A Systematic Review and Meta-Analysis Pedro Rafael Figueiredo, Serenella Tolomeo, J. Douglas Steele, Alexander Baldacchino Neuroscience and Biobehavioral Reviews, 2019 Doi : 10.1016/j.neubiorev.2019.10.014   "Une méta-analyse échoue à mettre en évidence une "toxicité" de l'usage du cannabis à long terme, sur les fonctions neuropsychologiques cognitives"   Highlights  A meta-analysis was conducted to assess the neuropsychological impact of cannabis.  A limited association was found between chronic cannabis use and neurocognitive deficits.  Memory and chronic cannabis smoking were linked. ABSTRACT Cannabis is currently the most used illicit substance in the world with a global widespread distribution. Although its acute neurocognitive effects on human behaviour have [...]

Lire la suite

The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain : How Cannabis Diminished Prescription Opioid Usage, Kevin M. Takakuwa et al., 2020

The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain : How Cannabis Diminished Prescription Opioid Usage Kevin M. Takakuwa, Jeffrey Y. Hergenrather, Frances S. Shofer, and Raquel M. Schears Cannabis and Cannabinoid Research, 2020, Volume X, Number X, 1-8. Doi : 10.1089/can.2019.0039 Abstract Objective : To determine if cannabis may be used as an alternative or adjunct treatment for intermittent and chronic prescription opioid users. Design : Retrospective cohort study. Setting : A single-center cannabis medical practice site in California. Patients : A total of 180 patients who had a chief complaint of low back pain were identified (International Classification of Diseases, 10th [...]

Lire la suite

IACM-Bulletin du 14 Février 2020

IACM-Bulletin du 14 Février 2020 Science/Animal: Le cannabigerol est efficace contre les infections par des bactéries résistantes aux antibiotiques Economy/Écologie: Données sur la quantité d'électricité consommée par l'industrie du cannabis Science/Homme: Environ la moitié des patients souffrant de lombalgie ont pu arrêter toute consommation d'opioïdes après avoir commencé la consommation de cannabis Europe/ONU: La Commission Européenne propose un vote unifié de l'UE sur la programmation de l’OMS sur le cannabis Science/Homme: De nombreux patients atteints d'arthrite consomment du cannabis Science/Homme: Le cannabis peut être utile contre l'insomnie chez les personnes âgées souffrant de douleur [...]

Lire la suite

What Should I Know About Medical Cannabis ?, Michael A. Incze et al., 2020

What Should I KnowAboutMedical Cannabis ? Michael A. Incze, MD, MSEd; Deepika Slawek, MD,MS, MPH; Chinazo O. Cunningham, MD,MS The JAMA Internal Medicine Patient Page, Online : February 11, 2020 doi : 10.1001/jamainternmed.2020.0018   What Is Cannabis and How Is It Used ? • Cannabis (ie, marijuana) is a plant that contains a complex mixture of chemicals called cannabinoids. Examples of cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD). • Whereas THC is primarily responsible for the psychoactive effects (euphoria) of cannabis, CBD may decrease pain but causes far fewer psychoactive effects than THC. • Cannabis is used medically as purified cannabinoids (eg, CBD), synthetic cannabinoids (eg, dronabinol), or [...]

Lire la suite

Bibliographie : Cannabidiol (CBD), Docteur Christian SUEUR, GRECC, février 2020.

Bibliographie : Cannabidiol (CBD) Docteur Christian SUEUR, GRECC, février 2020.     voir aussi : Bibliographie : Cannabis et Cannabinoïdes en Psychiatrie, Bibliographie : Cannabinoïdes et neuroprotection Bibliographie : Cannabinoïdes et épilepsie Bibliographie : Interactions et antagonisme THC - CBD Bibliographie : Effets indésirables du Cannabis (thérapeutique) sur la Santé mentale Bibliographie : Cannabinoïdes, Dépression et Troubles de l’Humeur Bibliographie : Cannabinoïdes et PTSD Bibliographie : Cannabinoïdes et TSA/TED/psychoses infantiles Bibliographie : Cannabinoïdes et Maladies Neurodégénératives

Lire la suite